Literature DB >> 24849703

Retinal cavernous hemangioma: fifty-two years of clinical follow-up with clinicopathologic correlation.

Jerry A Shields1, Ralph C Eagle, Madeleine Q Ewing, Sara E Lally, Carol L Shields.   

Abstract

PURPOSE: To report long-term follow-up and histopathology of a retinal cavernous hemangioma and to review the literature on this subject.
METHODS: A newborn girl was noted immediately after birth to a have hyphema and vitreous hemorrhage in her left eye. The bleeding recurred throughout childhood and the etiology was not determined. Upon referral at age 22, a large retinal cavernous hemangioma was first recognized and recurrent hemorrhages continued, eventually leading to pain and secondary glaucoma. The patient declined treatment. At age 52, the hemangioma was stable in size, but ocular pain and blindness necessitated enucleation.
RESULTS: During the 52-year course, the fundus mass did not enlarge, but numerous episodes of hyphema and vitreous hemorrhage led to chronic glaucoma and eventual blindness. The main histopathologic finding in the disorganized globe was a retinal mass composed of large endothelial-lined vascular channels with thin walls, typical of a retinal cavernous hemangioma. The tumor extended anteriorly into the ciliary body, explaining the recurrent hyphemas. Additional chronic features included extensive fibrosis of the entire anterior segment, iris, and retina with proliferative vitreoretinopathy and widespread intraocular hemosiderosis from chronic hemorrhage. The patient has been free of pain since enucleation.
CONCLUSION: Retinal cavernous hemangioma is a congenital stationary lesion that can cause recurrent intraocular hemorrhage, fibrosis, glaucoma, pain, and blindness, requiring enucleation. Retinal cavernous should be included in the differential diagnosis of childhood hyphema and vitreous hemorrhage.

Entities:  

Mesh:

Year:  2014        PMID: 24849703     DOI: 10.1097/IAE.0000000000000232

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Retinal cavernous haemangioma treated by proton beam therapy.

Authors:  Amir Mahdjoubi; Rémi Dendale; Livia Lumbroso-Le Rouic; Laurence Desjardins; Nathalie Cassoux
Journal:  Int Ophthalmol       Date:  2017-02-21       Impact factor: 2.031

2.  Therapeutic surprise! Photodynamic therapy for cavernous haemangioma of the disc.

Authors:  Mahesh P Shanmugam; Rajesh Ramanjulu; Shyamal Dwivedi; Aditya Barigali; Ajith Havanje
Journal:  Indian J Ophthalmol       Date:  2017-08       Impact factor: 1.848

3.  A Case of Retinal Cavernous Hemangioma Diagnosed with Spectral Domain Optical Coherence Tomography.

Authors:  Kyuyeon Cho; Kunho Bae; Jong Min Kim; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2017-05-12

4.  Analysis of the characteristics of optical coherence tomography angiography for retinal cavernous hemangioma: A case report.

Authors:  Shuyuan Lyu; Ming Zhang; Ruikang K Wang; Yunxia Gao; Qinqin Zhang; Xiaoxue Min
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

5.  Multimodal imaging in a case of a congenital retinal macrovessel associated with a retinal cavernous hemangioma: a case report.

Authors:  Walid Zbiba; Issam Eddine Elleuch; Sana Sayadi; Meriem Laadheri
Journal:  BMC Ophthalmol       Date:  2020-02-04       Impact factor: 2.209

6.  Case report: Vitreous hemorrhage as the presenting sign of retinal cavernous hemangioma in a newborn.

Authors:  Benjamin J Fowler; Lilla Simon; Nathan L Scott; Catherin I Negron; Audina M Berrocal
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-22

7.  Recurrent Vitreous Hemorrhage in a Case of Retinal Cavernous Hemangioma: A Rare Presentation.

Authors:  Hossein Hasanpour; Alireza Ramezani; Saeed Karimi
Journal:  J Ophthalmic Vis Res       Date:  2016 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.